DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Leukeran (Chlorambucil) - Squamous Cell Carcinoma of Skin - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Squamous Cell Carcinoma of Skin (4)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Leukeran (Chlorambucil) where reactions include squamous cell carcinoma of skin. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Leukeran side effects in 48 year old female

Reported by a individual with unspecified qualification from United States on 2011-12-22

Patient: 48 year old female

Reactions: Squamous Cell Carcinoma of Skin

Drug(s) suspected as cause:
Arava
    Indication: Behcet's Syndrome
    Start date: 2007-06-01

Cellcept
    Indication: Behcet's Syndrome
    Start date: 2001-01-01
    End date: 2001-09-01

Colchicine
    Indication: Behcet's Syndrome
    Start date: 1999-10-01
    End date: 2002-12-01

Colchicine
    Start date: 2004-08-01

Cycloserine
    Indication: Behcet's Syndrome
    Start date: 2000-05-01
    End date: 2001-01-06

Cytoxan
    Start date: 2003-03-01
    End date: 2003-04-01

Cytoxan
    Start date: 2003-08-01
    End date: 2003-08-01

Cytoxan
    Start date: 2003-02-01
    End date: 2003-02-01

Cytoxan
    Start date: 2003-03-01
    End date: 2003-03-01

Cytoxan
    Start date: 2003-10-01
    End date: 2004-05-01

Cytoxan
    Indication: Behcet's Syndrome
    Start date: 2002-12-01
    End date: 2002-12-01

Cytoxan
    Start date: 2003-05-01
    End date: 2003-07-01

Cytoxan
    Start date: 2003-01-01
    End date: 2003-01-01

Cytoxan
    Start date: 2003-09-01
    End date: 2003-09-01

Dapsone
    Indication: Behcet's Syndrome
    Start date: 1999-09-01
    End date: 2000-05-01

Dapsone
    Start date: 2003-06-01
    End date: 2005-09-01

Enbrel
    Indication: Behcet's Syndrome
    Start date: 2004-09-01
    End date: 2005-02-01

Imuran
    Start date: 2007-01-01
    End date: 2007-03-01

Imuran
    Indication: Behcet's Syndrome
    Start date: 2005-02-01
    End date: 2005-04-01

Leukeran
    Indication: Behcet's Syndrome
    Start date: 2001-11-01
    End date: 2002-04-01

Leukeran
    Start date: 2002-06-01
    End date: 2002-09-01

Leukeran
    Start date: 2002-04-01
    End date: 2002-06-01

Methotrexate
    Indication: Behcet's Syndrome
    Start date: 1998-10-01
    End date: 1999-07-01

Plaquenil
    Start date: 2002-06-01
    End date: 2004-08-01

Plaquenil
    Indication: Behcet's Syndrome
    Start date: 1999-07-01
    End date: 2002-05-01

Plaquenil
    Start date: 2004-08-01

Prednisone TAB
    Indication: Behcet's Syndrome

Remicade
    Indication: Behcet's Syndrome
    Start date: 2005-04-01
    End date: 2005-05-01

Remicade
    Start date: 2005-05-01
    End date: 2005-07-01

Remicade
    Start date: 2005-07-01
    End date: 2005-09-01

Remicade
    Start date: 2005-09-01
    End date: 2006-02-01

Rituxan
    Start date: 2006-07-05
    End date: 2006-07-05

Rituxan
    Indication: Behcet's Syndrome
    Start date: 2006-06-01
    End date: 2006-06-01

Other drugs received by patient: Sertraline Hydrochloride; Terbutaline Sulfate; Pregabalin; Acyclovir; Theophylline; Erythromycin; Esomeprazole Magnesium; Pentoxifylline; Fentanyl-100; Imiquimod; Fluticasone Propionate / Salmeterol; Folic Acid; Ipratropium Bromide and Albuterol Sulfate; Furosemide; Immune Globulin NOS; Imiquimod



Possible Leukeran side effects in 48 year old female

Reported by a physician from United States on 2011-12-13

Patient: 48 year old female

Reactions: Squamous Cell Carcinoma of Skin

Drug(s) suspected as cause:
Arava
    Dosage: 20 mg, daily
    Start date: 2007-06-01

Cellcept
    Dosage: 1000 mg, 2x/day
    Indication: Behcet's Syndrome
    Start date: 2001-01-01
    End date: 2001-09-01

Colchicine
    Dosage: 6 mg, 2x/day
    Indication: Behcet's Syndrome
    Start date: 1999-10-01
    End date: 2002-12-01

Colchicine
    Dosage: 6 mg, 2x/day
    Start date: 2004-08-01

Cyclosporine
    Dosage: unk
    Indication: Behcet's Syndrome
    Start date: 2000-05-01
    End date: 2001-01-06

Cytoxan
    Dosage: 500 mg, unk
    Start date: 2003-01-01

Cytoxan
    Dosage: 1250 mg, unk
    Start date: 2003-03-01

Cytoxan
    Dosage: 500 mg, unk
    Start date: 2003-05-01

Cytoxan
    Dosage: 1000 mg, unk
    Start date: 2003-09-01

Cytoxan
    Dosage: 750 mg, unk
    Start date: 2003-08-01

Cytoxan
    Dosage: 250 mg, unk
    Start date: 2002-12-01

Cytoxan
    Dosage: 500 mg, unk
    End date: 2004-05-01

Cytoxan
    Dosage: 750 mg, unk
    Start date: 2003-02-01

Cytoxan
    Dosage: 1000 mg, unk
    Start date: 2003-03-01

Cytoxan
    Dosage: 500 mg, unk
    Start date: 2003-07-01

Cytoxan
    Dosage: 1250 mg, unk
    Start date: 2003-04-01

Dapsone
    Dosage: 50 mg, daily
    Start date: 2003-06-01
    End date: 2005-09-01

Dapsone
    Dosage: 100 mg, 2x/day
    Indication: Behcet's Syndrome
    Start date: 1999-09-01
    End date: 2000-05-01

Enbrel
    Dosage: 25 mg, 2x/week
    Indication: Ankylosing Spondylitis
    Start date: 2004-09-01
    End date: 2005-02-01

Imuran
    Dosage: 150 mg, daily
    Indication: Behcet's Syndrome
    Start date: 2005-02-01
    End date: 2005-04-01

Imuran
    Dosage: 150 mg, daily
    Start date: 2007-01-01
    End date: 2007-03-01

Leukeran
    Dosage: 2 mg, unk
    Start date: 2002-06-01
    End date: 2002-09-01

Leukeran
    Dosage: 4 mg, daily
    Indication: Behcet's Syndrome
    Start date: 2001-11-01

Leukeran
    Dosage: 3 mg, unk
    Start date: 2002-04-01

Methotrexate
    Dosage: titrated from 7.5 mg up to 20 mg weekly
    Indication: Behcet's Syndrome
    Start date: 1998-10-01
    End date: 1999-07-01

Plaquenil
    Dosage: 300 mg, qd
    Indication: Behcet's Syndrome
    Start date: 1999-07-01
    End date: 2002-01-01

Plaquenil
    Dosage: 200 mg, 2x/day
    Start date: 2004-08-01

Plaquenil
    Dosage: 200 mg, daily
    Start date: 2002-06-01

Prednisone TAB
    Dosage: 10 mg, daily, occasional pulses
    Indication: Behcet's Syndrome

Remicade
    Dosage: 400 mg, unk
    Start date: 2005-05-01

Remicade
    Dosage: 300 mg, unk
    Start date: 2005-07-01

Remicade
    Dosage: 400 mg, unk
    Start date: 2005-11-01

Remicade
    Dosage: 400 mg, unk
    Start date: 2006-01-01
    End date: 2006-02-01

Remicade
    Dosage: 200 mg, unk
    Indication: Behcet's Syndrome
    Start date: 2005-04-01

Remicade
    Dosage: 400 mg, unk
    Start date: 2005-09-01

Rituxan
    Dosage: 1000 mg, unk
    Indication: Behcet's Syndrome
    Start date: 2006-06-01

Rituxan
    Dosage: 1000 mg, unk
    Start date: 2006-07-05

Other drugs received by patient: Fentanyl; Galenic / Fluticasone / Salmeterol /; Acyclovir; Folic Acid; Terbutaline Sulfate; Albuterol Sulfate and Ipratropium Bromide; Theophylline; Erythromycin; Esomeprazole Magnesium; Sertraline Hydrochloride; Furosemide; Pentoxifylline; Pregabalin



Possible Leukeran side effects in 48 year old female

Reported by a physician from United States on 2011-10-28

Patient: 48 year old female

Reactions: Renal Failure, Nausea, Mouth Ulceration, Anaemia, Squamous Cell Carcinoma of Skin, Neutropenia, Rash, Accidental Exposure

Drug(s) suspected as cause:
Arava
    Dosage: 20 mg daily
    Indication: Behcet's Syndrome

Cellcept
    Dosage: 1000 mg twice daily
    Indication: Behcet's Syndrome

Colchicine
    Dosage: 6 mg twice daily, 6 mg twice daily
    Indication: Behcet's Syndrome

Cyclosporine
    Indication: Behcet's Syndrome
    End date: 2001-01-06

Cytoxan
    Dosage: 250 mg, 250 mg, 500 mg, 750 mg, 1000 mg, 1250 mg, intravenous
    Indication: Behcet's Syndrome

Dapsone
    Dosage: titrated up to 100 mg twice daily, titrated up to 50 mg daily
    Indication: Behcet's Syndrome

Enbrel
    Dosage: 25 mg twice weekly
    Indication: Behcet's Syndrome

Imuran
    Dosage: titrated up to 150 mg daily
    Indication: Behcet's Syndrome

Leukeran
    Dosage: titrated up to 4 mg daily, 3 mg daily, 3 mg daily
    Indication: Behcet's Syndrome

Methotrexate
    Dosage: 7.5 mg per week, titrated up to 20 mg per week
    Indication: Behcet's Syndrome

Plaquenil
    Dosage: 300 mg daily, 200 mg daily, 200 mg twice daily, oral
    Administration route: Oral
    Indication: Behcet's Syndrome

Prednisone
    Dosage: 10 mg daily
    Indication: Behcet's Syndrome

Remicade
    Dosage: 200 mg, 300 mg, 400 mg, intravenous
    Indication: Behcet's Syndrome

Rituxan
    Dosage: 1000 mg, 1000 mg, intravenous
    Indication: Behcet's Syndrome
    End date: 2006-07-05

Other drugs received by patient: Terbutaline Sulfate; (Esomeprazole); Pregabalin; Acyclovir; (Fentanyl); Erythromycin; Sertraline Hydrochloride; Theophylline; Pentoxifylline; Furosemide; Folic Acid; Fluticasone Propionate / Salmeterol; Ipratropium Bromide and Albuterol Sulfate



Possible Leukeran side effects in 48 year old female

Reported by a physician from United States on 2011-10-19

Patient: 48 year old female

Reactions: Squamous Cell Carcinoma of Skin

Drug(s) suspected as cause:
Arava
    Indication: Behcet's Syndrome

Colchicine
    Indication: Behcet's Syndrome

Cyclosporine
    Indication: Behcet's Syndrome

Cytoxan
    Indication: Behcet's Syndrome

Dapsone
    Indication: Behcet's Syndrome

Enbrel
    Indication: Behcet's Syndrome

Imuran
    Indication: Behcet's Syndrome

Leukeran
    Indication: Behcet's Syndrome

Methotrexate
    Indication: Behcet's Syndrome

Mycophenolate Mofetil (Cellcept)
    Indication: Behcet's Syndrome

Plaquenil
    Indication: Behcet's Syndrome

Prednisone
    Indication: Behcet's Syndrome

Remicade
    Indication: Behcet's Syndrome

Rituxan
    Indication: Behcet's Syndrome

Other drugs received by patient: Pregabalin; Acyclovir; Folic Acid; Furosemide; Terbutaline Sulfate; Erythromycin; Esomeprazole Sodium; Pentoxifylline; Theophylline; Fentanyl-100; Fluticasone Propionate / Salmeterol; Sertraline Hydrochloride

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017